Prelude Capital Management’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,464
| Closed | -$262K | – | 1177 |
|
|
2025
Q1 | $262K | Sell |
34,464
-196,179
| -85% | -$1.49M | 0.02% | 682 |
|
|
2024
Q4 | $2.22M | Sell |
230,643
-166,281
| -42% | -$1.6M | 0.14% | 137 |
|
|
2024
Q3 | $2.35M | Sell |
396,924
-24,487
| -6% | -$145K | 0.14% | 158 |
|
|
2024
Q2 | $2.92M | Buy |
421,411
+110,440
| +36% | +$765K | 0.2% | 109 |
|
|
2024
Q1 | $2.39M | Buy |
310,971
+16,237
| +6% | +$125K | 0.13% | 179 |
|
|
2023
Q4 | $2.58M | Sell |
294,734
-67,932
| -19% | -$596K | 0.17% | 116 |
|
|
2023
Q3 | $2.64M | Buy |
+362,666
| New | +$2.64M | 0.17% | 111 |
|
|
2023
Q2 | – | Sell |
-12,411
| Closed | -$42.3K | – | 1155 |
|
|
2023
Q1 | $42.3K | Buy |
+12,411
| New | +$42.3K | ﹤0.01% | 914 |
|
|
2021
Q2 | – | Sell |
-14,102
| Closed | -$145K | – | 1520 |
|
|
2021
Q1 | $145K | Buy |
14,102
+755
| +6% | +$7.76K | ﹤0.01% | 971 |
|
|
2020
Q4 | $121K | Buy |
+13,347
| New | +$121K | ﹤0.01% | 710 |
|
|
2016
Q2 | – | Sell |
-12,500
| Closed | -$109K | – | 1601 |
|
|
2016
Q1 | $109K | Buy |
+12,500
| New | +$109K | 0.02% | 666 |
|
|
2015
Q4 | – | Sell |
-5,240
| Closed | -$51K | – | 1510 |
|
|
2015
Q3 | $51K | Sell |
5,240
-25,730
| -83% | -$250K | 0.01% | 976 |
|
|
2015
Q2 | $359K | Buy |
30,970
+13,470
| +77% | +$156K | 0.05% | 362 |
|
|
2015
Q1 | $182K | Buy |
17,500
+14,000
| +400% | +$146K | 0.03% | 673 |
|
|
2014
Q4 | $40K | Buy |
+3,500
| New | +$40K | 0.01% | 1283 |
|